SOPHARMA AD (20/2026) Sales revenues for December 2025
Report no 20/2026
- 20.01.2026, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (19/2026) Notification for sale of treasury shares
Report no 19/2026- 20.01.2026, 09:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (18/2026) Notification for sale of treasury shares
Report no 18/2026- 19.01.2026, 10:33
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (17/2026) Notification for sale of treasury shares
Report no 17/2026- 16.01.2026, 09:30
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (16/2026) Notification for sale of treasury shares
Report no 16/2026- 15.01.2026, 09:23
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (15/2026) Notification for sale of treasury shares
Report no 15/2026- 14.01.2026, 09:36
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (14/2026) Notification for sale of treasury shares
Report no 14/2026- 13.01.2026, 09:34
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (13/2026) Notification for sale of treasury shares
Report no 13/2026- 12.01.2026, 09:28
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (11/2026) Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 7 years
Report no 11/2026- 09.01.2026, 14:08
- Kategoria: Biznes i finanse
- Źródło: ESPI
